Switch to:
GuruFocus has detected 4 Warning Signs with Alexion Pharmaceuticals Inc $ALXN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Alexion Pharmaceuticals Inc (NAS:ALXN)
Revenue
$3,084 Mil (TTM As of Dec. 2016)

Alexion Pharmaceuticals Inc's revenue for the three months ended in Dec. 2016 was $831 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2016 was $3,084 Mil. Alexion Pharmaceuticals Inc's revenue per share for the three months ended in Dec. 2016 was $3.66. Its revenue per share for the trailing twelve months (TTM) ended in Dec. 2016 was $13.62.

Warning Sign:

Alexion Pharmaceuticals Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Alexion Pharmaceuticals Inc was 12.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 27.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 68.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using revenue per share data.

During the past 13 years, Alexion Pharmaceuticals Inc's highest 3-Year average Revenue per Share Growth Rate was 462.40% per year. The lowest was -68.50% per year. And the median was 38.80% per year.


Definition

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Alexion Pharmaceuticals Inc Revenue for the trailing twelve months (TTM) ended in Dec. 2016 was 701.038 (Mar. 2016 ) + 753.116 (Jun. 2016 ) + 799.106 (Sep. 2016 ) + 830.74 (Dec. 2016 ) = $3,084 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


• Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
• Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
• Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Related Terms

Net Income, Cost of Goods Sold, Operating Income, Pre-Tax Income, Growth Rate Calculation Example (GuruFocus)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Alexion Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Revenue 722593875417831,1341,5512,2342,6043,084

Alexion Pharmaceuticals Inc Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Revenue 555600600636667701701753799831
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK